NCT03139279View on ClinicalTrials.gov

Propofol and Dexmedetomidine Versus a Propofol Only Regimen for Sedation During Colonoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

May 4, 2018

Study Completion Date

July 19, 2018

Conditions
Colonoscopy
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine 0.3 ug/kg intravenous bolus

OTHER

Saline placebo

Intravenous saline/placebo

DRUG

Propofol

Propofol titrated intravenous boluses

Trial Locations (1)

11203

SUNY Downstate Medical Center, Brooklyn

All Listed Sponsors
lead

State University of New York - Downstate Medical Center

OTHER

NCT03139279 - Propofol and Dexmedetomidine Versus a Propofol Only Regimen for Sedation During Colonoscopy | Biotech Hunter | Biotech Hunter